Stocks · NYSE · Healthcare · United States
DGX — Quest Diagnostics Inc.
Quest Diagnostics Inc. (DGX) is a healthcare stock listed on NYSE (United States). At the close of September 29, 2026 it traded at 231.97 (-2.38% on the day), -3.5% over one month, +7.8% over three months, +25.0% over twelve months. The InvestMuse composite score is +34 on a −100 to +100 scale, a bullish read that ranks #306 of about 1,221 assets. The strongest of its nine dimensions are Chart patterns and zones (+60) and Fundamentals (+57); the weakest is Trend (-24). Its volatility regime from the hidden Markov model is Calm. 36 news articles in the last 30 days carried an average tone of +0.09 (on −1 to +1).
The facts
| Last close | 231.97 (September 29, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | -2.38% / -3.5% / +7.8% / +25.0% |
| 52-week range | 171.25 – 247.45 |
| Composite score | +34 / 100 · bullish view · rank #306 |
| Volatility regime (HMM) | Calm |
| Resistance levels | 88.00, 125.00 |
| Trailing P/E | 22.4 |
| Market cap | $23.7B |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)0
- Technical indicators+7
- Trend-24
- Support / resistance0
- Fundamentals+57
- Sector edge-4
- News sentiment+10
- Momentum+10
- Chart patterns and zones+60
How this read is made
Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.